Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Ayana Pharma
Ayana Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Doxorubicin
Doxorubicin
2021-10-12
Myeloid leukemia acute
,
Breast neoplasms
,
Ovarian neoplasms
,
Thyroid neoplasms
,
Gastrointestinal neoplasms
,
Lung neoplasms
,
Multiple myeloma
,
Neuroblastoma
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Urinary bladder neoplasms
,
Osteosarcoma
,
Hodgkin disease
,
Soft tissue neoplasms
,
Kaposi sarcoma
,
Wilms tumor
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Doxorubicin
b-cell lymphoma
,
neoplasms
,
hodgkin disease
,
breast neoplasms
,
neutropenia
,
chemotherapy-induced febrile neutropenia
,
lymphoma
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
Doxorubicin hydrochloride
b-cell lymphoma
,
neoplasms
,
hodgkin disease
,
breast neoplasms
,
neutropenia
,
chemotherapy-induced febrile neutropenia
,
lymphoma
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
inflammatory breast neoplasms
,
non-hodgkin lymphoma
,
mantle-cell lymphoma
Doxorubin
ovarian neoplasms
,
neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
sarcoma
,
rhabdomyosarcoma
,
disease progression
,
lymphoma
,
non-hodgkin lymphoma
,
breast neoplasms
Hydroxydaunomycin
aggression
,
recurrence
,
large b-cell lymphoma diffuse
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
osteosarcoma
,
benign fibrous histiocytoma
,
histiocytoma
,
malignant fibrous histiocytoma
,
b-cell chronic lymphocytic leukemia
,
reactive arthritis
,
pancreatic neoplasms
,
endocrine gland neoplasms
,
hodgkin disease
,
urinary bladder neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
adenocarcinoma
,
sarcoma
,
breast neoplasms
,
lymphoma
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
triple negative breast neoplasms
,
follicular lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use